Insider · CIK 0001843710
Yvonne Genovese
officer
Files at IT (GARTNER INC). First filing Dec 13, 2024, latest Mar 3, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $971k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IT: GARTNER INC
ITOct 9, 2026 · close 191.15
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 63Notable | GARTNER INC | $881k 1,740 shares | -26% | +4% from low-10% from high | |
| 39Weak | GARTNER INC | $90k 173 shares | -8% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 26, 2025 | IT GARTNER INC | SOpen-market sale Common Stock | -1,740 | $506.47 | $881k | 4,889 | Mar 3, 2025 |
| Feb 13, 2025 | IT GARTNER INC | MOption exercise Common Stock | +4,826 | $180.64 | $872k | 9,715 | Feb 18, 2025 |
| Feb 13, 2025 | IT GARTNER INC | DDisposition to issuer Common Stock | -1,686 | $517.17 | $872k | 8,029 | Feb 18, 2025 |
| Feb 13, 2025 | IT GARTNER INC | FTax withholding Common Stock | -1,400 | $517.17 | $724k | 6,629 | Feb 18, 2025 |
| Feb 13, 2025 | IT GARTNER INC | MOption exercise Stock Appreciation Rightsderivative | -4,826 | $0.00 | $0 | 0 | Feb 18, 2025 |
| Feb 10, 2025 | IT GARTNER INC | MOption exercise Common Stock | +1,937 | $0.00 | $0 | 5,711 | Feb 12, 2025 |
| Feb 10, 2025 | IT GARTNER INC | FTax withholding Common Stock | -822 | $528.87 | $435k | 4,889 | Feb 12, 2025 |
| Feb 10, 2025 | IT GARTNER INC | MOption exercise Restricted Stock Unitsderivative | -1,937 | $0.00 | $0 | 0 | Feb 12, 2025 |
| Feb 8, 2025 | IT GARTNER INC | MOption exercise Common Stock | +850 | $0.00 | $0 | 2,809 | Feb 10, 2025 |
| Feb 8, 2025 | IT GARTNER INC | FTax withholding Common Stock | -265 | $529.29 | $140k | 2,544 | Feb 10, 2025 |
| Feb 9, 2025 | IT GARTNER INC | MOption exercise Common Stock | +892 | $0.00 | $0 | 3,436 | Feb 10, 2025 |
| Feb 9, 2025 | IT GARTNER INC | FTax withholding Common Stock | -370 | $529.29 | $196k | 3,066 | Feb 10, 2025 |
| Feb 9, 2025 | IT GARTNER INC | MOption exercise Common Stock | +976 | $0.00 | $0 | 4,042 | Feb 10, 2025 |
| Feb 9, 2025 | IT GARTNER INC | FTax withholding Common Stock | -268 | $529.29 | $142k | 3,774 | Feb 10, 2025 |
| Feb 6, 2025 | IT GARTNER INC | AGrant or award Restricted Stock Unitsderivative | +3,400 | $0.00 | $0 | 3,400 | Feb 10, 2025 |
| Feb 6, 2025 | IT GARTNER INC | AGrant or award Stock Appreciation Rightsderivative | +3,757 | $0.00 | $0 | 3,757 | Feb 10, 2025 |
| Feb 8, 2025 | IT GARTNER INC | MOption exercise Restricted Stock Unitsderivative | -850 | $0.00 | $0 | 2,550 | Feb 10, 2025 |
| Feb 9, 2025 | IT GARTNER INC | MOption exercise Restricted Stock Unitsderivative | -892 | $0.00 | $0 | 1,784 | Feb 10, 2025 |
| Feb 9, 2025 | IT GARTNER INC | MOption exercise Restricted Stock Unitsderivative | -976 | $0.00 | $0 | 976 | Feb 10, 2025 |
| Dec 11, 2024 | IT GARTNER INC | SOpen-market sale Common Stock | -173 | $519.83 | $90k | 1,959 | Dec 13, 2024 |
| Nov 15, 2024 | IT GARTNER INC | MOption exercise Common Stock | +314 | $0.00 | $0 | 2,273 | Nov 19, 2024 |
| Nov 15, 2024 | IT GARTNER INC | FTax withholding Common Stock | -141 | $522.86 | $74k | 2,132 | Nov 19, 2024 |
| Nov 15, 2024 | IT GARTNER INC | MOption exercise Restricted Stock Unitsderivative | -314 | $0.00 | $0 | 0 | Nov 19, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.